IVACC.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$22M	-14.0%	$-0.23	$-0.29–$-0.17	—	1
2027	$30M	+39.5%	$-0.24	$-0.30–$-0.18	—	1
2028	$121M	+303.3%	$-0.13	$-0.24–$-0.02	—	2
2029	$166M	+37.2%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 5 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-20	$-0.05	$-0.06	-20.0%
2026-05-13	$-0.06	$-0.06	+0.0%
2026-02-16	$-0.06	$-0.10	-66.7%
2025-11-19	$-0.15	$-0.04	+74.1%
2025-08-29	$-0.20	$-0.05	+74.7%
2025-05-14	$-0.19	$-0.15	+20.5%
2025-02-13	$-0.19	$-0.19	+0.0%
2024-11-14	$-0.19

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
IVACC.STIntervacc AB (publ)	$1.01	+0.60%	$344M	—
ACARIX.STAcarix AB (publ)	$0.21	+0.47%	$238M	—
ACE.STAscelia Pharma AB (publ)	$0.61	-1.93%	$81M	—
ELIC.STElicera Therapeutics AB (publ)	$2.91	-2.18%	$194M	—
IMMU.STMendus AB (publ)	$6.22

Intervacc AB (publ)

Intervacc AB (publ) is a Swedish biotechnology company primarily engaged in the research and development of innovative vaccines designed to combat bacterial infections in animal health. The firm's vaccine pipeline targets various animals, including horses, piglets, and dairy cows, with its key product, Strangvac, specifically developed to prevent equine strangles. Beyond its current offerings, Intervacc is also advancing vaccines against Streptococcus suis and Staphylococcus aureus infections. In addition to vaccine development, the company distributes veterinary medicines and provides essential diagnostic services in veterinary bacteriology to clinics and stud farms. Headquartered in Hägersten, Sweden, Intervacc serves customers across the Nordic countries and the Baltic states.

www.intervacc.se

Employees: 16
IPO / List date: Apr 7, 2017
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds IVACC.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in IVACC.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded IVACC.ST yet.